UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Identification of N‑(4-((1R,3S,5S)‑3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies

Journal of medicinal chemistry, 2015-11, Vol.58 (21), p.8373-8386

2015

Volltextzugriff (PDF)

583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A349-A350

2020

Volltextzugriff (PDF)

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Molecular cancer therapeutics, 2022-06, Vol.21 (6), p.948-959

2022

Volltextzugriff (PDF)

Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73

Journal of medicinal chemistry, 2020-04, Vol.63 (8), p.3935-3955

2020

Volltextzugriff (PDF)

Discovery of Potent and Selective PI3Kγ Inhibitors

Journal of medicinal chemistry, 2020-10, Vol.63 (19), p.11235-11257

2020

Volltextzugriff (PDF)

Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)

Journal of medicinal chemistry, 2022-01, Vol.65 (2), p.1418-1444

2022

Volltextzugriff (PDF)

Abstract 1206: Discovery and characterization of AB521, a novel, potent, and selective hypoxia-inducible factor (HIF)-2α inhibitor

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1206-1206

2021

Volltextzugriff (PDF)

Abstract C050: A novel, potent, and selective hypoxia-inducible factor (HIF)-2α antagonist

Molecular cancer therapeutics, 2019-12, Vol.18 (12_Supplement), p.C050-C050

2019

Volltextzugriff (PDF)

Abstract P206: AB521 potently and selectively inhibits pro-tumorigenic gene transcription by Hypoxia-Inducible Factor (HIF)-2α in vitro and in vivo

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P206-P206

2021

Volltextzugriff (PDF)

Abstract 3862: AB474, a potent orally bioavailable inhibitor of arginase, for the treatment of cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3862-3862

2019

Volltextzugriff (PDF)

Discovery of Potent and Selective 7‑Azaindole Isoindolinone-Based PI3Kγ Inhibitors

ACS medicinal chemistry letters, 2020-11, Vol.11 (11), p.2244-2252

2020

Volltextzugriff (PDF)

Abstract A157: Preclinical pharmacokinetic and pharmacodynamic characterization of AB680, a small-molecule CD73 inhibitor for cancer immunotherapy

Cancer immunology research, 2019-02, Vol.7 (2_Supplement), p.A157-A157

2019

Volltextzugriff (PDF)

Contributing out of her poverty: A study of the widow in Luke-Acts

Eddy, Gaylyn Elaine Ginn

1999

Volltextzugriff (PDF)

Visuospatial and Numerical Cognitive Deficits in Children with Chromosome 22Q11.2 Deletion Syndrome

Cortex, 2005-04, Vol.41 (2), p.145-155

2005

Volltextzugriff (PDF)

First genome-wide CNV mapping in FELIS CATUS using next generation sequencing data

BMC genomics, 2018-12, Vol.19 (1), p.895-895, Article 895

2018

Volltextzugriff (PDF)

Bringing an Integral Approach to the Field of Technology Diffusion Research

Organizational Dynamics of Technology-Based Innovation: Diversifying the Research Agenda, p.469-474

Volltextzugriff (PDF)

Cooloola Coast: Noosa to Fraser island. The aboriginal and settler histories of a unique environment

Australian Journal of Politics and History, 2002, Vol.48 (1), p.103-104

2002

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(16)

Publikationsform

Sprache

Englisch
(17)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(9)
Life Sciences & Biomedicine
(8)
Animals
(5)
Chemistry, Medicinal
(5)
Humans
(5)
Pharmacology & Pharmacy
(5)
Amides - Chemistry
(2)
Cancer
(2)
Drug Design
(2)
Gene Expression
(2)
Mice
(2)
Molecular Docking Simulation
(2)
Phosphoinositide-3 Kinase Inhibitors - Pharmacology
(2)
Rats
(2)
Social Sciences
(2)
Structure-Activity Relationship
(2)
Abnormalities, Multiple - Genetics
(1)
Aborigines
(1)
Adenosine - Metabolism
(1)
Adenosine - Pharmacology
(1)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of N‑(4-((1R,3S,5S)‑3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies

583 Novel, potent, and selective inhibitors of hypoxia-inducible factor (HIF)-2α reverse pro-tumorigenic transcriptional programming in cancer, stromal, and immune cells

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity

Discovery of Potent and Selective Non-Nucleotide Small Molecule Inhibitors of CD73

Discovery of Potent and Selective PI3Kγ Inhibitors

Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)

Abstract 1206: Discovery and characterization of AB521, a novel, potent, and selective hypoxia-inducible factor (HIF)-2α inhibitor

Abstract C050: A novel, potent, and selective hypoxia-inducible factor (HIF)-2α antagonist

Abstract P206: AB521 potently and selectively inhibits pro-tumorigenic gene transcription by Hypoxia-Inducible Factor (HIF)-2α in vitro and in vivo

Abstract 3862: AB474, a potent orally bioavailable inhibitor of arginase, for the treatment of cancer

Discovery of Potent and Selective 7‑Azaindole Isoindolinone-Based PI3Kγ Inhibitors

Abstract A157: Preclinical pharmacokinetic and pharmacodynamic characterization of AB680, a small-molecule CD73 inhibitor for cancer immunotherapy

Contributing out of her poverty: A study of the widow in Luke-Acts

Visuospatial and Numerical Cognitive Deficits in Children with Chromosome 22Q11.2 Deletion Syndrome

First genome-wide CNV mapping in FELIS CATUS using next generation sequencing data

Bringing an Integral Approach to the Field of Technology Diffusion Research

Cooloola Coast: Noosa to Fraser island. The aboriginal and settler histories of a unique environment

Suchergebnisse filtern